nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxymorphone—CYP2D6—Vinorelbine—ovarian cancer	0.0982	0.255	CbGbCtD
Oxymorphone—CYP3A4—Topotecan—ovarian cancer	0.0886	0.23	CbGbCtD
Oxymorphone—CYP3A4—Vinorelbine—ovarian cancer	0.0625	0.162	CbGbCtD
Oxymorphone—CYP3A4—Paclitaxel—ovarian cancer	0.0439	0.114	CbGbCtD
Oxymorphone—CYP2D6—Doxorubicin—ovarian cancer	0.0372	0.0964	CbGbCtD
Oxymorphone—CYP3A4—Docetaxel—ovarian cancer	0.0317	0.0822	CbGbCtD
Oxymorphone—CYP3A4—Doxorubicin—ovarian cancer	0.0236	0.0613	CbGbCtD
Oxymorphone—Naloxone—TLR4—ovarian cancer	0.0101	0.561	CrCbGaD
Oxymorphone—Naloxone—ESR1—ovarian cancer	0.00283	0.157	CrCbGaD
Oxymorphone—Naltrexone—ABCB1—ovarian cancer	0.00165	0.0916	CrCbGaD
Oxymorphone—Buprenorphine—ABCB1—ovarian cancer	0.00121	0.0673	CrCbGaD
Oxymorphone—Naloxone—ABCB1—ovarian cancer	0.0012	0.0668	CrCbGaD
Oxymorphone—Diarrhoea—Topotecan—ovarian cancer	0.00111	0.00186	CcSEcCtD
Oxymorphone—Lethargy—Epirubicin—ovarian cancer	0.0011	0.00185	CcSEcCtD
Oxymorphone—Urticaria—Vinorelbine—ovarian cancer	0.0011	0.00184	CcSEcCtD
Oxymorphone—Urinary tract disorder—Docetaxel—ovarian cancer	0.0011	0.00184	CcSEcCtD
Oxymorphone—Abdominal pain—Vinorelbine—ovarian cancer	0.00109	0.00183	CcSEcCtD
Oxymorphone—Body temperature increased—Vinorelbine—ovarian cancer	0.00109	0.00183	CcSEcCtD
Oxymorphone—Urethral disorder—Docetaxel—ovarian cancer	0.00109	0.00182	CcSEcCtD
Oxymorphone—Diarrhoea—Melphalan—ovarian cancer	0.00108	0.00182	CcSEcCtD
Oxymorphone—Diplopia—Epirubicin—ovarian cancer	0.00108	0.00182	CcSEcCtD
Oxymorphone—Nausea—Chlorambucil—ovarian cancer	0.00108	0.00181	CcSEcCtD
Oxymorphone—Vision blurred—Paclitaxel—ovarian cancer	0.00107	0.0018	CcSEcCtD
Oxymorphone—Hot flush—Doxorubicin—ovarian cancer	0.00107	0.0018	CcSEcCtD
Oxymorphone—Visual impairment—Docetaxel—ovarian cancer	0.00107	0.00179	CcSEcCtD
Oxymorphone—Dizziness—Topotecan—ovarian cancer	0.00107	0.00179	CcSEcCtD
Oxymorphone—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00106	0.00178	CcSEcCtD
Oxymorphone—Agitation—Paclitaxel—ovarian cancer	0.00105	0.00176	CcSEcCtD
Oxymorphone—Eye disorder—Docetaxel—ovarian cancer	0.00104	0.00174	CcSEcCtD
Oxymorphone—Flushing—Docetaxel—ovarian cancer	0.00103	0.00173	CcSEcCtD
Oxymorphone—Cardiac disorder—Docetaxel—ovarian cancer	0.00103	0.00173	CcSEcCtD
Oxymorphone—Vomiting—Topotecan—ovarian cancer	0.00103	0.00172	CcSEcCtD
Oxymorphone—Vertigo—Paclitaxel—ovarian cancer	0.00102	0.00172	CcSEcCtD
Oxymorphone—Syncope—Paclitaxel—ovarian cancer	0.00102	0.00171	CcSEcCtD
Oxymorphone—Lethargy—Doxorubicin—ovarian cancer	0.00102	0.00171	CcSEcCtD
Oxymorphone—Hypersensitivity—Vinorelbine—ovarian cancer	0.00102	0.00171	CcSEcCtD
Oxymorphone—Dermatitis—Topotecan—ovarian cancer	0.00102	0.00171	CcSEcCtD
Oxymorphone—Morphine—ABCB1—ovarian cancer	0.00101	0.0564	CrCbGaD
Oxymorphone—Headache—Topotecan—ovarian cancer	0.00101	0.0017	CcSEcCtD
Oxymorphone—Palpitations—Paclitaxel—ovarian cancer	0.00101	0.00169	CcSEcCtD
Oxymorphone—Angiopathy—Docetaxel—ovarian cancer	0.00101	0.00169	CcSEcCtD
Oxymorphone—Vomiting—Melphalan—ovarian cancer	0.00101	0.00169	CcSEcCtD
Oxymorphone—Dehydration—Epirubicin—ovarian cancer	0.00101	0.00169	CcSEcCtD
Oxymorphone—Immune system disorder—Docetaxel—ovarian cancer	0.001	0.00168	CcSEcCtD
Oxymorphone—Loss of consciousness—Paclitaxel—ovarian cancer	0.001	0.00168	CcSEcCtD
Oxymorphone—Diplopia—Doxorubicin—ovarian cancer	0.001	0.00168	CcSEcCtD
Oxymorphone—Mediastinal disorder—Docetaxel—ovarian cancer	0.001	0.00168	CcSEcCtD
Oxymorphone—Dermatitis—Melphalan—ovarian cancer	0.000997	0.00167	CcSEcCtD
Oxymorphone—Asthenia—Vinorelbine—ovarian cancer	0.000992	0.00166	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000988	0.00166	CcSEcCtD
Oxymorphone—Convulsion—Paclitaxel—ovarian cancer	0.000988	0.00166	CcSEcCtD
Oxymorphone—Hypertension—Paclitaxel—ovarian cancer	0.000984	0.00165	CcSEcCtD
Oxymorphone—Pruritus—Vinorelbine—ovarian cancer	0.000979	0.00164	CcSEcCtD
Oxymorphone—Mental disorder—Docetaxel—ovarian cancer	0.000972	0.00163	CcSEcCtD
Oxymorphone—Chest pain—Paclitaxel—ovarian cancer	0.000971	0.00163	CcSEcCtD
Oxymorphone—Anxiety—Paclitaxel—ovarian cancer	0.000967	0.00162	CcSEcCtD
Oxymorphone—Malnutrition—Docetaxel—ovarian cancer	0.000966	0.00162	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000964	0.00162	CcSEcCtD
Oxymorphone—Nausea—Topotecan—ovarian cancer	0.00096	0.00161	CcSEcCtD
Oxymorphone—Dry mouth—Paclitaxel—ovarian cancer	0.000949	0.00159	CcSEcCtD
Oxymorphone—Diarrhoea—Vinorelbine—ovarian cancer	0.000946	0.00159	CcSEcCtD
Oxymorphone—Abdominal distension—Epirubicin—ovarian cancer	0.000942	0.00158	CcSEcCtD
Oxymorphone—Nausea—Melphalan—ovarian cancer	0.00094	0.00158	CcSEcCtD
Oxymorphone—Confusional state—Paclitaxel—ovarian cancer	0.000938	0.00157	CcSEcCtD
Oxymorphone—Dehydration—Doxorubicin—ovarian cancer	0.000931	0.00156	CcSEcCtD
Oxymorphone—Oedema—Paclitaxel—ovarian cancer	0.00093	0.00156	CcSEcCtD
Oxymorphone—Shock—Paclitaxel—ovarian cancer	0.000915	0.00154	CcSEcCtD
Oxymorphone—Dizziness—Vinorelbine—ovarian cancer	0.000915	0.00153	CcSEcCtD
Oxymorphone—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000915	0.00153	CcSEcCtD
Oxymorphone—Nervous system disorder—Paclitaxel—ovarian cancer	0.000912	0.00153	CcSEcCtD
Oxymorphone—Tachycardia—Paclitaxel—ovarian cancer	0.000908	0.00152	CcSEcCtD
Oxymorphone—Skin disorder—Paclitaxel—ovarian cancer	0.000904	0.00152	CcSEcCtD
Oxymorphone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000899	0.00151	CcSEcCtD
Oxymorphone—Anorexia—Paclitaxel—ovarian cancer	0.000887	0.00149	CcSEcCtD
Oxymorphone—Vomiting—Vinorelbine—ovarian cancer	0.000879	0.00148	CcSEcCtD
Oxymorphone—Dermatitis—Vinorelbine—ovarian cancer	0.000871	0.00146	CcSEcCtD
Oxymorphone—Abdominal distension—Doxorubicin—ovarian cancer	0.000871	0.00146	CcSEcCtD
Oxymorphone—Hypotension—Paclitaxel—ovarian cancer	0.000869	0.00146	CcSEcCtD
Oxymorphone—Headache—Vinorelbine—ovarian cancer	0.000867	0.00145	CcSEcCtD
Oxymorphone—Syncope—Docetaxel—ovarian cancer	0.000866	0.00145	CcSEcCtD
Oxymorphone—Palpitations—Docetaxel—ovarian cancer	0.000854	0.00143	CcSEcCtD
Oxymorphone—Loss of consciousness—Docetaxel—ovarian cancer	0.000849	0.00142	CcSEcCtD
Oxymorphone—Weight decreased—Epirubicin—ovarian cancer	0.000846	0.00142	CcSEcCtD
Oxymorphone—Insomnia—Paclitaxel—ovarian cancer	0.000841	0.00141	CcSEcCtD
Oxymorphone—Pneumonia—Epirubicin—ovarian cancer	0.000839	0.00141	CcSEcCtD
Oxymorphone—Convulsion—Docetaxel—ovarian cancer	0.000837	0.0014	CcSEcCtD
Oxymorphone—Hypertension—Docetaxel—ovarian cancer	0.000834	0.0014	CcSEcCtD
Oxymorphone—Dyspnoea—Paclitaxel—ovarian cancer	0.000829	0.00139	CcSEcCtD
Oxymorphone—Somnolence—Paclitaxel—ovarian cancer	0.000827	0.00139	CcSEcCtD
Oxymorphone—Chest pain—Docetaxel—ovarian cancer	0.000823	0.00138	CcSEcCtD
Oxymorphone—Nausea—Vinorelbine—ovarian cancer	0.000822	0.00138	CcSEcCtD
Oxymorphone—Dyspepsia—Paclitaxel—ovarian cancer	0.000819	0.00137	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000817	0.00137	CcSEcCtD
Oxymorphone—Decreased appetite—Paclitaxel—ovarian cancer	0.000809	0.00136	CcSEcCtD
Oxymorphone—Dry mouth—Docetaxel—ovarian cancer	0.000805	0.00135	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000803	0.00135	CcSEcCtD
Oxymorphone—Fatigue—Paclitaxel—ovarian cancer	0.000802	0.00135	CcSEcCtD
Oxymorphone—Constipation—Paclitaxel—ovarian cancer	0.000796	0.00133	CcSEcCtD
Oxymorphone—Pain—Paclitaxel—ovarian cancer	0.000796	0.00133	CcSEcCtD
Oxymorphone—Confusional state—Docetaxel—ovarian cancer	0.000795	0.00133	CcSEcCtD
Oxymorphone—Oedema—Docetaxel—ovarian cancer	0.000789	0.00132	CcSEcCtD
Oxymorphone—Weight decreased—Doxorubicin—ovarian cancer	0.000783	0.00131	CcSEcCtD
Oxymorphone—Pneumonia—Doxorubicin—ovarian cancer	0.000776	0.0013	CcSEcCtD
Oxymorphone—Shock—Docetaxel—ovarian cancer	0.000776	0.0013	CcSEcCtD
Oxymorphone—Nervous system disorder—Docetaxel—ovarian cancer	0.000773	0.0013	CcSEcCtD
Oxymorphone—Tachycardia—Docetaxel—ovarian cancer	0.00077	0.00129	CcSEcCtD
Oxymorphone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000767	0.00129	CcSEcCtD
Oxymorphone—Skin disorder—Docetaxel—ovarian cancer	0.000766	0.00128	CcSEcCtD
Oxymorphone—Bradycardia—Epirubicin—ovarian cancer	0.000762	0.00128	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000761	0.00128	CcSEcCtD
Oxymorphone—Anorexia—Docetaxel—ovarian cancer	0.000752	0.00126	CcSEcCtD
Oxymorphone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000739	0.00124	CcSEcCtD
Oxymorphone—Urticaria—Paclitaxel—ovarian cancer	0.000739	0.00124	CcSEcCtD
Oxymorphone—Hypotension—Docetaxel—ovarian cancer	0.000737	0.00124	CcSEcCtD
Oxymorphone—Body temperature increased—Paclitaxel—ovarian cancer	0.000735	0.00123	CcSEcCtD
Oxymorphone—Abdominal pain—Paclitaxel—ovarian cancer	0.000735	0.00123	CcSEcCtD
Oxymorphone—Urethral disorder—Epirubicin—ovarian cancer	0.000734	0.00123	CcSEcCtD
Oxymorphone—Visual impairment—Epirubicin—ovarian cancer	0.000721	0.00121	CcSEcCtD
Oxymorphone—Insomnia—Docetaxel—ovarian cancer	0.000713	0.0012	CcSEcCtD
Oxymorphone—Bradycardia—Doxorubicin—ovarian cancer	0.000705	0.00118	CcSEcCtD
Oxymorphone—Dyspnoea—Docetaxel—ovarian cancer	0.000703	0.00118	CcSEcCtD
Oxymorphone—Somnolence—Docetaxel—ovarian cancer	0.000701	0.00118	CcSEcCtD
Oxymorphone—Eye disorder—Epirubicin—ovarian cancer	0.0007	0.00117	CcSEcCtD
Oxymorphone—Flushing—Epirubicin—ovarian cancer	0.000695	0.00117	CcSEcCtD
Oxymorphone—Cardiac disorder—Epirubicin—ovarian cancer	0.000695	0.00117	CcSEcCtD
Oxymorphone—Dyspepsia—Docetaxel—ovarian cancer	0.000694	0.00116	CcSEcCtD
Oxymorphone—Decreased appetite—Docetaxel—ovarian cancer	0.000686	0.00115	CcSEcCtD
Oxymorphone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000685	0.00115	CcSEcCtD
Oxymorphone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000684	0.00115	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000681	0.00114	CcSEcCtD
Oxymorphone—Fatigue—Docetaxel—ovarian cancer	0.00068	0.00114	CcSEcCtD
Oxymorphone—Angiopathy—Epirubicin—ovarian cancer	0.000679	0.00114	CcSEcCtD
Oxymorphone—Urethral disorder—Doxorubicin—ovarian cancer	0.000679	0.00114	CcSEcCtD
Oxymorphone—Immune system disorder—Epirubicin—ovarian cancer	0.000676	0.00113	CcSEcCtD
Oxymorphone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000675	0.00113	CcSEcCtD
Oxymorphone—Constipation—Docetaxel—ovarian cancer	0.000674	0.00113	CcSEcCtD
Oxymorphone—Pain—Docetaxel—ovarian cancer	0.000674	0.00113	CcSEcCtD
Oxymorphone—Visual impairment—Doxorubicin—ovarian cancer	0.000668	0.00112	CcSEcCtD
Oxymorphone—Asthenia—Paclitaxel—ovarian cancer	0.000668	0.00112	CcSEcCtD
Oxymorphone—Pruritus—Paclitaxel—ovarian cancer	0.000658	0.0011	CcSEcCtD
Oxymorphone—Mental disorder—Epirubicin—ovarian cancer	0.000656	0.0011	CcSEcCtD
Oxymorphone—Malnutrition—Epirubicin—ovarian cancer	0.000652	0.00109	CcSEcCtD
Oxymorphone—Feeling abnormal—Docetaxel—ovarian cancer	0.00065	0.00109	CcSEcCtD
Oxymorphone—Eye disorder—Doxorubicin—ovarian cancer	0.000647	0.00109	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000645	0.00108	CcSEcCtD
Oxymorphone—Flushing—Doxorubicin—ovarian cancer	0.000643	0.00108	CcSEcCtD
Oxymorphone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000643	0.00108	CcSEcCtD
Oxymorphone—Flatulence—Epirubicin—ovarian cancer	0.000642	0.00108	CcSEcCtD
Oxymorphone—Tension—Epirubicin—ovarian cancer	0.00064	0.00107	CcSEcCtD
Oxymorphone—Diarrhoea—Paclitaxel—ovarian cancer	0.000637	0.00107	CcSEcCtD
Oxymorphone—Nervousness—Epirubicin—ovarian cancer	0.000633	0.00106	CcSEcCtD
Oxymorphone—Angiopathy—Doxorubicin—ovarian cancer	0.000628	0.00105	CcSEcCtD
Oxymorphone—Immune system disorder—Doxorubicin—ovarian cancer	0.000626	0.00105	CcSEcCtD
Oxymorphone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000624	0.00105	CcSEcCtD
Oxymorphone—Body temperature increased—Docetaxel—ovarian cancer	0.000623	0.00105	CcSEcCtD
Oxymorphone—Abdominal pain—Docetaxel—ovarian cancer	0.000623	0.00105	CcSEcCtD
Oxymorphone—Dizziness—Paclitaxel—ovarian cancer	0.000615	0.00103	CcSEcCtD
Oxymorphone—Vision blurred—Epirubicin—ovarian cancer	0.000614	0.00103	CcSEcCtD
Oxymorphone—Mental disorder—Doxorubicin—ovarian cancer	0.000607	0.00102	CcSEcCtD
Oxymorphone—Malnutrition—Doxorubicin—ovarian cancer	0.000603	0.00101	CcSEcCtD
Oxymorphone—Agitation—Epirubicin—ovarian cancer	0.000599	0.001	CcSEcCtD
Oxymorphone—Flatulence—Doxorubicin—ovarian cancer	0.000594	0.000997	CcSEcCtD
Oxymorphone—Tension—Doxorubicin—ovarian cancer	0.000592	0.000992	CcSEcCtD
Oxymorphone—Vomiting—Paclitaxel—ovarian cancer	0.000592	0.000992	CcSEcCtD
Oxymorphone—Dermatitis—Paclitaxel—ovarian cancer	0.000586	0.000983	CcSEcCtD
Oxymorphone—Nervousness—Doxorubicin—ovarian cancer	0.000586	0.000982	CcSEcCtD
Oxymorphone—Vertigo—Epirubicin—ovarian cancer	0.000586	0.000982	CcSEcCtD
Oxymorphone—Syncope—Epirubicin—ovarian cancer	0.000584	0.00098	CcSEcCtD
Oxymorphone—Headache—Paclitaxel—ovarian cancer	0.000583	0.000978	CcSEcCtD
Oxymorphone—Hypersensitivity—Docetaxel—ovarian cancer	0.000581	0.000974	CcSEcCtD
Oxymorphone—Palpitations—Epirubicin—ovarian cancer	0.000576	0.000966	CcSEcCtD
Oxymorphone—Loss of consciousness—Epirubicin—ovarian cancer	0.000573	0.000961	CcSEcCtD
Oxymorphone—Vision blurred—Doxorubicin—ovarian cancer	0.000568	0.000953	CcSEcCtD
Oxymorphone—Asthenia—Docetaxel—ovarian cancer	0.000566	0.000949	CcSEcCtD
Oxymorphone—Convulsion—Epirubicin—ovarian cancer	0.000565	0.000947	CcSEcCtD
Oxymorphone—Hypertension—Epirubicin—ovarian cancer	0.000563	0.000944	CcSEcCtD
Oxymorphone—Pruritus—Docetaxel—ovarian cancer	0.000558	0.000936	CcSEcCtD
Oxymorphone—Chest pain—Epirubicin—ovarian cancer	0.000555	0.000931	CcSEcCtD
Oxymorphone—Agitation—Doxorubicin—ovarian cancer	0.000554	0.000929	CcSEcCtD
Oxymorphone—Anxiety—Epirubicin—ovarian cancer	0.000553	0.000927	CcSEcCtD
Oxymorphone—Nausea—Paclitaxel—ovarian cancer	0.000553	0.000927	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000551	0.000924	CcSEcCtD
Oxymorphone—Dry mouth—Epirubicin—ovarian cancer	0.000543	0.00091	CcSEcCtD
Oxymorphone—Vertigo—Doxorubicin—ovarian cancer	0.000542	0.000909	CcSEcCtD
Oxymorphone—Syncope—Doxorubicin—ovarian cancer	0.000541	0.000907	CcSEcCtD
Oxymorphone—Diarrhoea—Docetaxel—ovarian cancer	0.00054	0.000905	CcSEcCtD
Oxymorphone—Confusional state—Epirubicin—ovarian cancer	0.000536	0.0009	CcSEcCtD
Oxymorphone—Palpitations—Doxorubicin—ovarian cancer	0.000533	0.000894	CcSEcCtD
Oxymorphone—Oedema—Epirubicin—ovarian cancer	0.000532	0.000892	CcSEcCtD
Oxymorphone—Loss of consciousness—Doxorubicin—ovarian cancer	0.00053	0.000889	CcSEcCtD
Oxymorphone—Shock—Epirubicin—ovarian cancer	0.000523	0.000878	CcSEcCtD
Oxymorphone—Convulsion—Doxorubicin—ovarian cancer	0.000522	0.000876	CcSEcCtD
Oxymorphone—Nervous system disorder—Epirubicin—ovarian cancer	0.000522	0.000875	CcSEcCtD
Oxymorphone—Dizziness—Docetaxel—ovarian cancer	0.000521	0.000875	CcSEcCtD
Oxymorphone—Hypertension—Doxorubicin—ovarian cancer	0.000521	0.000873	CcSEcCtD
Oxymorphone—Tachycardia—Epirubicin—ovarian cancer	0.000519	0.000871	CcSEcCtD
Oxymorphone—Skin disorder—Epirubicin—ovarian cancer	0.000517	0.000867	CcSEcCtD
Oxymorphone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000514	0.000862	CcSEcCtD
Oxymorphone—Chest pain—Doxorubicin—ovarian cancer	0.000513	0.000861	CcSEcCtD
Oxymorphone—Anxiety—Doxorubicin—ovarian cancer	0.000512	0.000858	CcSEcCtD
Oxymorphone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00051	0.000855	CcSEcCtD
Oxymorphone—Anorexia—Epirubicin—ovarian cancer	0.000507	0.00085	CcSEcCtD
Oxymorphone—Dry mouth—Doxorubicin—ovarian cancer	0.000502	0.000842	CcSEcCtD
Oxymorphone—Vomiting—Docetaxel—ovarian cancer	0.000501	0.000841	CcSEcCtD
Oxymorphone—Hypotension—Epirubicin—ovarian cancer	0.000497	0.000834	CcSEcCtD
Oxymorphone—Dermatitis—Docetaxel—ovarian cancer	0.000497	0.000833	CcSEcCtD
Oxymorphone—Confusional state—Doxorubicin—ovarian cancer	0.000496	0.000832	CcSEcCtD
Oxymorphone—Headache—Docetaxel—ovarian cancer	0.000494	0.000829	CcSEcCtD
Oxymorphone—Oedema—Doxorubicin—ovarian cancer	0.000492	0.000825	CcSEcCtD
Oxymorphone—Shock—Doxorubicin—ovarian cancer	0.000484	0.000812	CcSEcCtD
Oxymorphone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000483	0.000809	CcSEcCtD
Oxymorphone—Insomnia—Epirubicin—ovarian cancer	0.000481	0.000807	CcSEcCtD
Oxymorphone—Tachycardia—Doxorubicin—ovarian cancer	0.00048	0.000806	CcSEcCtD
Oxymorphone—Skin disorder—Doxorubicin—ovarian cancer	0.000478	0.000802	CcSEcCtD
Oxymorphone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000476	0.000798	CcSEcCtD
Oxymorphone—Dyspnoea—Epirubicin—ovarian cancer	0.000474	0.000795	CcSEcCtD
Oxymorphone—Somnolence—Epirubicin—ovarian cancer	0.000473	0.000793	CcSEcCtD
Oxymorphone—Anorexia—Doxorubicin—ovarian cancer	0.000469	0.000787	CcSEcCtD
Oxymorphone—Nausea—Docetaxel—ovarian cancer	0.000468	0.000786	CcSEcCtD
Oxymorphone—Dyspepsia—Epirubicin—ovarian cancer	0.000468	0.000785	CcSEcCtD
Oxymorphone—Decreased appetite—Epirubicin—ovarian cancer	0.000462	0.000775	CcSEcCtD
Oxymorphone—Hypotension—Doxorubicin—ovarian cancer	0.00046	0.000771	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000459	0.00077	CcSEcCtD
Oxymorphone—Fatigue—Epirubicin—ovarian cancer	0.000459	0.000769	CcSEcCtD
Oxymorphone—Pain—Epirubicin—ovarian cancer	0.000455	0.000763	CcSEcCtD
Oxymorphone—Constipation—Epirubicin—ovarian cancer	0.000455	0.000763	CcSEcCtD
Oxymorphone—Insomnia—Doxorubicin—ovarian cancer	0.000445	0.000747	CcSEcCtD
Oxymorphone—Dyspnoea—Doxorubicin—ovarian cancer	0.000439	0.000736	CcSEcCtD
Oxymorphone—Feeling abnormal—Epirubicin—ovarian cancer	0.000438	0.000735	CcSEcCtD
Oxymorphone—Somnolence—Doxorubicin—ovarian cancer	0.000438	0.000734	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000435	0.000729	CcSEcCtD
Oxymorphone—Dyspepsia—Doxorubicin—ovarian cancer	0.000433	0.000727	CcSEcCtD
Oxymorphone—Decreased appetite—Doxorubicin—ovarian cancer	0.000428	0.000718	CcSEcCtD
Oxymorphone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000425	0.000713	CcSEcCtD
Oxymorphone—Fatigue—Doxorubicin—ovarian cancer	0.000424	0.000712	CcSEcCtD
Oxymorphone—Urticaria—Epirubicin—ovarian cancer	0.000423	0.000709	CcSEcCtD
Oxymorphone—Pain—Doxorubicin—ovarian cancer	0.000421	0.000706	CcSEcCtD
Oxymorphone—Constipation—Doxorubicin—ovarian cancer	0.000421	0.000706	CcSEcCtD
Oxymorphone—Abdominal pain—Epirubicin—ovarian cancer	0.00042	0.000705	CcSEcCtD
Oxymorphone—Body temperature increased—Epirubicin—ovarian cancer	0.00042	0.000705	CcSEcCtD
Oxymorphone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000406	0.00068	CcSEcCtD
Oxymorphone—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000402	0.000675	CcSEcCtD
Oxymorphone—Hypersensitivity—Epirubicin—ovarian cancer	0.000392	0.000657	CcSEcCtD
Oxymorphone—Urticaria—Doxorubicin—ovarian cancer	0.000391	0.000656	CcSEcCtD
Oxymorphone—Abdominal pain—Doxorubicin—ovarian cancer	0.000389	0.000653	CcSEcCtD
Oxymorphone—Body temperature increased—Doxorubicin—ovarian cancer	0.000389	0.000653	CcSEcCtD
Oxymorphone—Asthenia—Epirubicin—ovarian cancer	0.000382	0.00064	CcSEcCtD
Oxymorphone—Pruritus—Epirubicin—ovarian cancer	0.000376	0.000631	CcSEcCtD
Oxymorphone—Diarrhoea—Epirubicin—ovarian cancer	0.000364	0.00061	CcSEcCtD
Oxymorphone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000363	0.000608	CcSEcCtD
Oxymorphone—Asthenia—Doxorubicin—ovarian cancer	0.000353	0.000592	CcSEcCtD
Oxymorphone—Dizziness—Epirubicin—ovarian cancer	0.000352	0.00059	CcSEcCtD
Oxymorphone—Pruritus—Doxorubicin—ovarian cancer	0.000348	0.000584	CcSEcCtD
Oxymorphone—Vomiting—Epirubicin—ovarian cancer	0.000338	0.000567	CcSEcCtD
Oxymorphone—Diarrhoea—Doxorubicin—ovarian cancer	0.000337	0.000565	CcSEcCtD
Oxymorphone—Dermatitis—Epirubicin—ovarian cancer	0.000335	0.000562	CcSEcCtD
Oxymorphone—Headache—Epirubicin—ovarian cancer	0.000333	0.000559	CcSEcCtD
Oxymorphone—Dizziness—Doxorubicin—ovarian cancer	0.000325	0.000546	CcSEcCtD
Oxymorphone—Nausea—Epirubicin—ovarian cancer	0.000316	0.00053	CcSEcCtD
Oxymorphone—Vomiting—Doxorubicin—ovarian cancer	0.000313	0.000525	CcSEcCtD
Oxymorphone—Dermatitis—Doxorubicin—ovarian cancer	0.00031	0.00052	CcSEcCtD
Oxymorphone—Headache—Doxorubicin—ovarian cancer	0.000308	0.000517	CcSEcCtD
Oxymorphone—Nausea—Doxorubicin—ovarian cancer	0.000292	0.00049	CcSEcCtD
